|
| Exchange Disseminated Time 27/10/2016 16:01:13 | Lincoln Pharmaceuticals Ltd has informed BSE that the Meeting of the Board of Directors of the Company is scheduled to be held on November 10, 2016, to consider and approve the following:
1. Un-audited Consolidated and Standalone Financial Results of the Company for the Quarter and half year ended on September 30, 2016.
2. Delisting of Equity Shares of the Company from Ahmedabad Stock Exchange Limited pursuant to SEBI (Delisting of Equity Shares) Regulations, 2009. As amended from time to time.
In view of above, the trading window will remain close for the Promoters, Directors, Insiders, Designated Persons and the Connected Persons from the date of this letter and shall reopen after the expiry of 48 hours from the time the result becomes generally available. |
|
|